Top German Pharma Boehringer Wins US Approval for Cancer Drug
Summary by Colorado Springs Gazette
6 Articles
6 Articles

+2 Reposted by 2 other sources
Top German pharma Boehringer wins US approval for cancer drug
Boehringer Ingelheim GmbH won approval in the U.S. for its drug to treat a challenging form of lung cancer, offering a growth avenue for the privately-held German pharmaceuticals company.
·Colorado Springs, United States
Read Full ArticleUS FDA approves Boehringer Ingelheim’s lung cancer treatment - Regional Media News
(Reuters) -The U.S. Food and Drug Administration said on Friday it has approved Boehringer Ingelheim’s drug for patients with a type of advanced lung cancer who have received prior treatment. The drug, branded as Hernexeos, is intended for previously treated patients with non-squamous non-small cell lung cancer whose tumors have a specific genetic mutation. The regulator’s approval was based on a study in which Hernexeos helped about 75% of pati…
Coverage Details
Total News Sources6
Leaning Left1Leaning Right0Center2Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 33%
C 67%
Factuality
To view factuality data please Upgrade to Premium